Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 9, 2016 - Issue 10
Submit an article Journal homepage
512
Views
18
CrossRef citations to date
0
Altmetric
Review

Targeted therapies in thyroid cancer: an extensive review of the literature

Athanasios BikasDivision of Endocrinology, Department of Medicine, MedStar Washington Hospital Center, Washington, DC, USA
,
Shivangi VachhaniDivision of Endocrinology, Department of Medicine, MedStar Washington Hospital Center, Washington, DC, USA
,
Kirk JensenDepartment of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
,
Vasyl VaskoDepartment of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
&
Kenneth D. BurmanDivision of Endocrinology, Department of Medicine, MedStar Washington Hospital Center, Washington, DC, USACorrespondence[email protected]
Pages 1299-1313 | Received 15 Apr 2016, Accepted 17 Jun 2016, Published online: 15 Jul 2016

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Diana P. Sousa, Marta Pojo, Ana T. Pinto, Valeriano Leite, Ana Teresa Serra & Branca M. Cavaco. (2020) Nobiletin Alone or in Combination with Cisplatin Decreases the Viability of Anaplastic Thyroid Cancer Cell Lines. Nutrition and Cancer 72:2, pages 352-363.
Read now

Articles from other publishers (17)

Yue Huang, Yaoxin Wang, Sining Liu, Wen-Xia Chen & Zhengmin Xu. (2023) An integrative analysis of the tumor suppressors and oncogenes from sexual dimorphism and gene expression alteration features in thyroid cancer. Cancer Biomarkers, pages 1-16.
Crossref
Jing Zhang, Aomei Zhao, Xi Jia, Xinru Li, Yiqian Liang, Yan Liu, Xin Xie, Xijie Qu, Qi Wang, Yuemin Zhang, Rui Gao, Yan Yu & Aimin Yang. (2022) Sinomenine Hydrochloride Promotes TSHR-Dependent Redifferentiation in Papillary Thyroid Cancer. International Journal of Molecular Sciences 23:18, pages 10709.
Crossref
Angelika Buczyńska, Iwona Sidorkiewicz, Adam Jacek Krętowski, Monika Zbucka-Krętowska & Agnieszka Adamska. (2022) Metformin Intervention—A Panacea for Cancer Treatment?. Cancers 14:5, pages 1336.
Crossref
延泽 刘. (2022) Research Progress of BRAF V600E Gene Mutation in Papillary Thyroid Carcinoma. Advances in Clinical Medicine 12:09, pages 8499-8507.
Crossref
Maaike Dotinga, Dennis Vriens, Floris van Velden, Linda Heijmen, James Nagarajah, Rodney Hicks, Ellen Kapiteijn & Lioe-Fee de Geus-Oei. (2020) Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 64:3.
Crossref
Min Hwa Shin, Jiyoung Kim, Siyoung A. Lim, Jeongsoo Kim & Kyung-Mi Lee. (2020) Current Insights into Combination Therapies with MAPK Inhibitors and Immune Checkpoint Blockade. International Journal of Molecular Sciences 21:7, pages 2531.
Crossref
Shuiying Zhao, Yanyan Zhao, Qingzhu Wang, Zhizhen Li, Xiaojun Ma, Lina Wu, Wen Li, Mengmeng Du, Hongfei Ji & Guijun Qin. (2020) LDOC1 is differentially expressed in thyroid cancer and display tumor‐suppressive function in papillary thyroid carcinoma. Cell Biology International 44:4, pages 985-997.
Crossref
Hongxia Shang, Junyu Zhao, Jinming Yao, Huanjun Wang, Jianjun Dong & Lin Liao. (2020) Nevirapine Increases Sodium/Iodide Symporter-Mediated Radioiodide Uptake by Activation of TSHR/cAMP/CREB/PAX8 Signaling Pathway in Dedifferentiated Thyroid Cancer. Frontiers in Oncology 10.
Crossref
Nigel Fleeman, Rachel Houten, Adrian Bagust, Marty Richardson, Sophie Beale, Angela Boland, Yenal Dundar, Janette Greenhalgh, Juliet Hounsome, Rui Duarte & Aditya Shenoy. (2020) Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation. Health Technology Assessment 24:2, pages 1-180.
Crossref
Xiaolin Yang, Geling Liu, Weijuan Li, Luyang Zang, Ding Li, Qianqian Wang, Fang Yu & Xiuxiu Xiang. (2019) Silencing of zinc finger protein 703 inhibits medullary thyroid carcinoma cell proliferation in�vitro and in�vivo. Oncology Letters.
Crossref
Leila ShobabCristiane Gomes-LimaAlexander ZeymoRebecca FeldmanJacqueline JonklaasLeonard WartofskyKenneth D. Burman. (2019) Clinical, Pathological, and Molecular Profiling of Radioactive Iodine Refractory Differentiated Thyroid Cancer. Thyroid 29:9, pages 1262-1268.
Crossref
Sheng Wang, Dexi Zhou, Zhenyu Xu, Jing Song, Xueyi Qian, Xiongwen Lv & Jiajie Luan. (2019) Anti-tumor Drug Targets Analysis: Current Insight and Future Prospect. Current Drug Targets 20:11, pages 1180-1202.
Crossref
Athanasios Bikas, Kirk Jensen, Aneeta Patel, John Costello, Gregory Kaltsas, Victoria Hoperia, Leonard Wartofsky, Kenneth Burman & Vasyl Vasko. (2019) Mitotane induces mitochondrial membrane depolarization and apoptosis in thyroid cancer cells. International Journal of Oncology.
Crossref
George E. Naoum, Michael Morkos, Brian Kim & Waleed Arafat. (2018) Novel targeted therapies and immunotherapy for advanced thyroid cancers. Molecular Cancer 17:1.
Crossref
Elvina ALMURADOVA, İlgın YILDIRIM ŞİMŞİR, Mehmet ERDOĞAN, Şevki ÇETİNKALP, Füsun SAYGILI & Ahmet Gökhan ÖZGEN. (2017) İshal ile başvuran bir medüller tiroid kanseri olgusu: MEN 2B sendromuA case of medullary thyroid carcinoma presenting with diarrhea: MEN 2B syndrome. Ege Tıp Dergisi 56:3, pages 160-161.
Crossref
Hai Song, Chuwen Lin, Erica Yao, Kuan Zhang, Xiaoling Li, Qingzhe Wu & Pao-Tien Chuang. (2017) Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma. Journal of Biological Chemistry 292:9, pages 3888-3899.
Crossref
Paola Caria, Silvia Cantara, Daniela Frau, Furio Pacini, Roberta Vanni & Tinuccia Dettori. (2016) Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma. International Journal of Molecular Sciences 17:10, pages 1759.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.